Johnson & Johnson

NYSE: JNJ
$164.42
-$0.40 (-0.2%)
Real Time Data Delayed 15 Min.

JNJ Articles

It's no secret that investors love dividends. Here are 10 solid companies that have raised dividends for their investors for at least 50 consecutive years.
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Johnson & Johnson still cannot escape the shadow of its Johnson's Baby Powder brand talc and asbestos lawsuits and overhang.
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price. We have also added in some additional color on these companies as well.
Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Now that the fourth-quarter earnings reporting season has kicked off, more major companies will be sharing their results this week, including Comcast, Ford and Intel.
These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been.
These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic strength of 2018 is not repeated in 2019.
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.
Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.